Assessment of therapy response to Regorafenib by 18 F-DOPA-PET/CT in patients with recurrent high-grade gliomas: a case series

DiscussionThese preliminary findings suggest that18F-DOPA PET/CT allows an early and reliable assessment of metabolic response to the REG treatment. A major advantage of PET seems to be obtained in patients in whom MR is unable to differentiate non-response vs tumor pseudo-progression.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research